Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.

Abstract excerpt

DISEASE OVERVIEW: Atypical chronic myeloid leukemia (aCML) and myelodysplastic/myeloproliferative (MDS/MPN) neoplasms, not otherwise specified (NOS), are MDS/MPN overlap neoplasms characterized by leukocytosis, in the absence of monocytosis and eosinophilia, with <20% blasts in the blood and bone marrow. DIAGNOSIS: aCML, previously known as aCML, BCR::ABL1 negative, was renamed as aCML by the ICC classification,...

Topics

• Humans
• Aged
• Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
• Myelodysplastic Syndromes
• Leukocytosis
• Myelodysplastic-Myeloproliferative Diseases
• Leukemia, Myelomonocytic, Chronic
• Thrombocytosis
• Mutation
• Risk Assessment